| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050259401 |
| P356 | DOI | 10.1385/IR:28:3:167 |
| P698 | PubMed publication ID | 14713712 |
| P2093 | author name string | Wanjun Chen | |
| Sharon M Wahl | |||
| P2860 | cites work | TGF-beta signal transduction | Q22003891 |
| Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling | Q24290353 | ||
| Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase | Q24290743 | ||
| Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype | Q24293121 | ||
| Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death | Q24563654 | ||
| A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA | Q24610268 | ||
| Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 | ||
| Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes | Q24673317 | ||
| Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
| CTLA-4 ligation blocks CD28-dependent T cell activation | Q24678229 | ||
| Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
| The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis | Q28137622 | ||
| TGF-beta: from latent to active | Q28141342 | ||
| B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes | Q28143530 | ||
| Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease | Q28202655 | ||
| TGF-beta: receptors, signaling pathways and autoimmunity | Q28217375 | ||
| Making sense of latent TGFbeta activation | Q28217641 | ||
| CTLA-4 can function as a negative regulator of T cell activation | Q28235866 | ||
| Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4 | Q28284177 | ||
| Tolerance, danger, and the extended family | Q29547532 | ||
| Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF | Q29615685 | ||
| Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4 | Q29619280 | ||
| A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
| Functional diversity of helper T lymphocytes | Q29619415 | ||
| CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
| How cells read TGF-beta signals | Q29619993 | ||
| TGF-beta signaling from receptors to the nucleus | Q30829255 | ||
| The ever-increasing complexity of TGF-beta signaling | Q31032888 | ||
| TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression | Q33338215 | ||
| Regulatory T cells: key controllers of immunologic self-tolerance | Q33941140 | ||
| Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro | Q33942128 | ||
| Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells | Q34094070 | ||
| Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
| CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
| An overview of regulatory T cells | Q34374544 | ||
| CD4(+) regulatory T cells | Q34418015 | ||
| Type 1 T regulatory cells. | Q34448429 | ||
| The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance | Q34448471 | ||
| Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance | Q34503328 | ||
| Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
| Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. | Q34515741 | ||
| Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta | Q34517421 | ||
| Cutting edge: CTLA-4 (CD152) differentially regulates mitogen-activated protein kinases (extracellular signal-regulated kinase and c-Jun N-terminal kinase) in CD4+ T cells from receptor/ligand-deficient mice | Q34527377 | ||
| Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. | Q34529123 | ||
| Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide | Q34531452 | ||
| Transforming growth factor-beta in T-cell biology | Q34572232 | ||
| CD4+ CD25+ suppressor T cells: more questions than answers | Q34716304 | ||
| Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis | Q34719541 | ||
| Acquisition of lymphokine-producing phenotype by CD4+ T cells | Q34724514 | ||
| Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala). | Q34828735 | ||
| T cell anergy | Q35019694 | ||
| Two major Smad pathways in TGF-beta superfamily signalling. | Q35026971 | ||
| CD3-specific antibody-induced active tolerance: from bench to bedside | Q35058543 | ||
| Human allograft acceptance is associated with immune regulation | Q35128097 | ||
| Loss of receptors for transforming growth factor beta in human T-cell malignancies. | Q35546848 | ||
| Lacrimal gland inflammation is responsible for ocular pathology in TGF-beta 1 null mice | Q35764100 | ||
| Transforming growth factor beta: the good, the bad, and the ugly | Q36363951 | ||
| CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells | Q36366857 | ||
| Certified professionals: CD4(+)CD25(+) suppressor T cells | Q36369181 | ||
| Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation | Q36369726 | ||
| Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussi | Q36369855 | ||
| Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells | Q36401309 | ||
| Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1. | Q36525918 | ||
| Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients | Q37356987 | ||
| Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model | Q37383110 | ||
| Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift | Q38975096 | ||
| Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen | Q40701079 | ||
| Physical and functional interaction between GATA-3 and Smad3 allows TGF-beta regulation of GATA target genes | Q40757292 | ||
| Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. | Q40968846 | ||
| Positive selection of thymocytes bearing alpha beta T cell receptors. | Q41429671 | ||
| Anergic T cells as suppressor cells in vitro | Q41461549 | ||
| Plasminogen/plasminogen activator and growth factor activation. | Q41730913 | ||
| Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. | Q41907086 | ||
| Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells | Q41908906 | ||
| Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood | Q41988688 | ||
| The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis | Q43845888 | ||
| A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood | Q46284741 | ||
| CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations. | Q52165458 | ||
| TGF-beta: 20 years and counting. | Q53534770 | ||
| Infectious immunological tolerance | Q54033162 | ||
| Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation | Q56904469 | ||
| Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration | Q56904883 | ||
| Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells | Q56905940 | ||
| Polarization of naive CD4+ T cells toward the Th1 subset by CTLA-4 costimulation | Q56906094 | ||
| TGF-beta mediates CTLA-4 suppression of cellular immunity in murine kalaazar | Q56906232 | ||
| Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2 | Q56906783 | ||
| Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts | Q70548406 | ||
| Immune dysregulation in TGF-beta 1-deficient mice | Q72108750 | ||
| Self-nonself discrimination revisited. Introduction | Q74054487 | ||
| TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu | Q74070676 | ||
| The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells | Q74286639 | ||
| Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen | Q74286698 | ||
| Oral delivery of group A streptococcal cell walls augments circulating TGF-beta and suppresses streptococcal cell wall arthritis | Q77620202 | ||
| The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality | Q78033315 | ||
| Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells | Q78806915 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 167-179 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Immunologic Research | Q15754981 |
| P1476 | title | TGF-beta: how tolerant can it be? | |
| P478 | volume | 28 |
| Q34233101 | Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus. |
| Q35223959 | Engineering fibrin-binding TGF-β1 for sustained signaling and contractile function of MSC based vascular constructs |
| Q53041510 | Hepatic stellate cells induce immunotolerance of islet allografts. |
| Q36133140 | Immunotherapy for pancreatic cancer - science driving clinical progress |
| Q24815128 | Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray |
| Q28236080 | Osteopontin and mucosal protection |
| Q81121285 | Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection |
| Q36997273 | T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology |
| Q28263622 | TGF-beta: a mobile purveyor of immune privilege |
| Q35668744 | TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells |
| Q37402405 | Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation |
| Q24804340 | Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases |
Search more.